证券之星消息，1月23日金属新材料板块较上一交易日上涨3.39%，斯瑞新材领涨。当日上证指数报收于 4136.16，上涨0.33%。深证成指报收于14439.66，上涨0.79%。金属新材料板块个股涨跌见下表： 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。 | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 300855 | 图南股份 | 37.64 | -3.81% | 10.68万 | 4.05亿 | | 300811 | 铂科新材 | 80.42 | -2.99% | 13.45万 | 10.76亿 | | 300835 | 龙磁科技 | 72.52 | -2.92% | 5.06万 | 3.67 亿 | | 603124 | 江南新材 | 93.51 | -1.61% | 1.52万 | 1.41亿 | | 605158 | 华达新材 | 8.50 | -0.58% | 5.47万 | 4633.78万 | | 3 ...

1月22日，云路股份跌1.64%，成交额1.59亿元。两融数据显示，当日云路股份获融资买入额3706.94万 元，融资偿还1336.59万元，融资净买入2370.35万元。截至1月22日，云路股份融资融券余额合计1.73亿 元。 融资方面，云路股份当日融资买入3706.94万元。当前融资余额1.71亿元，占流通市值的1.34%，融资余 额超过近一年90%分位水平，处于高位。 分红方面，云路股份A股上市后累计派现4.18亿元。近三年，累计派现3.78亿元。 机构持仓方面，截止2025年9月30日，云路股份十大流通股东中，景顺长城新能源产业股票A类 （011328）位居第五大流通股东，持股268.81万股，相比上期增加33.40万股。景顺长城优选混合 （260101）位居第九大流通股东，持股82.09万股，为新进股东。景顺长城环保优势股票（001975）位 居第十大流通股东，持股80.72万股，为新进股东。景顺长城成长龙头一年持有期混合A类（011058）退 出十大流通股东之列。 责任编辑：小浪快报 融券方面，云路股份1月22日融券偿还0.00股，融券卖出0.00股，按当日收盘价计算，卖出金额0.00元； 融券余 ...

南财智讯1月23日电，图南股份在投资者关系活动中表示，公司未来将基于现有核心竞争优势，巩固主 营业务产品，重点发展高端民品业务，力争形成军品配套与高端民品协同发展的产品结构。公司将继续 专注于高温合金等先进金属材料的研发与生产，为航空航天、舰船、能源等高端装备制造领域提供高性 能材料和制品，不断拓宽产品链，拓展国内外市场，提升持续盈利能力与投资者回报水平。 ...

Core Viewpoint - The medical titanium alloy industry is experiencing significant growth driven by an aging population and increasing chronic disease rates, leading to higher demand for medical devices and implants. The market size for medical titanium alloys in China is projected to reach 4.32 billion yuan in 2024, reflecting a 9% year-on-year increase [1][6]. Group 1: Industry Overview - Medical titanium alloys are specialized biocompatible materials used for manufacturing human implants, characterized by excellent biocompatibility, high specific strength (over 300 MPa·cm³/g), and moderate elastic modulus (approximately 110 GPa) [3]. - The development of medical titanium alloys has progressed through three generations, with the latest generation focusing on reducing toxicity and improving compatibility with human bone [3][4]. Group 2: Market Size and Growth - The market for medical titanium alloys is expected to continue growing, with the orthopedic implant sector (including artificial joints and spinal correction devices) holding the largest market share at 50%, projected to reach 2.16 billion yuan in 2024 [6]. - Factors driving demand in the orthopedic implant sector include an aging population (over 300 million people aged 60 and above in China), advancements in medical technology, and supportive policies [6]. Group 3: Competitive Landscape - The medical titanium alloy industry features a concentrated head with leading companies like Baotai Co., West Superconductor, and Xiangtou Jintian dominating the mid-to-high-end market, while smaller firms focus on niche segments to avoid direct competition [7]. - Key players in the industry include Jiangsu Tiangong Technology Co., Baotai Co., and others, with a focus on R&D and production of titanium and titanium alloy materials [7][8]. Group 4: Industry Trends - The industry is moving towards functional upgrades of materials to meet diverse clinical needs, emphasizing the development of new alloys that are aluminum and vanadium-free for enhanced biocompatibility [9]. - Integration of smart technologies into titanium alloy products is becoming a significant innovation direction, with the incorporation of micro-sensors for real-time monitoring of implant conditions [10]. - The industry is accelerating its green and low-carbon transformation, focusing on energy-efficient production processes and recycling systems for titanium alloy materials to reduce waste and production costs [11].

Group 1: Company Operations and Production Capacity - The subsidiary Tunan Components has established an automated production line for small and medium-sized aerospace parts, achieving an annual production capacity of 500,000 units [2] - The subsidiary Tunan Intelligent has completed the construction of an automated production line with an annual capacity of 10 million aerospace small and medium-sized parts [2] - The production lines are currently in a ramp-up phase, with efforts focused on accelerating production delivery and revenue recognition based on existing orders [2] Group 2: Core Competitive Advantages - The company's core competitive advantages include a strong customer base accumulated over years, comprehensive certification, a full industry chain for high-temperature alloy products, product differentiation, technological research and development, and quality control [2][3] - Continuous improvement of overall service capabilities has been achieved through investment projects, significantly enhancing the company's product development and production capacity [3] Group 3: Future Development Strategy - The company aims to consolidate its existing main business products while focusing on the development of high-end civilian products, striving for a product structure that supports sustainable high-quality development [3] - The strategy includes deepening involvement in the advanced metal materials industry, providing high-performance alloy materials and products for high-end equipment manufacturing sectors such as aerospace, naval vessels, and energy [3] - The company is committed to research and development of new technologies and products, expanding its product chain, and establishing itself as a well-known enterprise in the domestic and international markets with independent intellectual property and core competitiveness [3]

云路股份1月22日大宗交易平台共发生3笔成交，合计成交量6.52万股，成交金额639.94万元。成交价格 均为98.15元，相对今日收盘价折价8.00%。从参与大宗交易营业部来看，机构专用席位共出现在1笔成 交的买方或卖方营业部中，合计成交金额为201.21万元，净买入201.21万元。 进一步统计，近3个月内该股累计发生46笔大宗交易，合计成交金额为1.75亿元。 证券时报·数据宝统计显示，云路股份今日收盘价为106.68元，下跌1.64%，日换手率为1.24%，成交额 为1.59亿元，全天主力资金净流出359.20万元，近5日该股累计上涨3.05%，近5日资金合计净流出 1189.77万元。 | 成交量 | 成交金额 | 成交价 | 相对当日收盘 | | | | --- | --- | --- | --- | --- | --- | | （万 | （万元） | 格 | 折溢价（%） | 买方营业部 | 卖方营业部 | | 股） | | （元） | | | | | 2.27 | 222.80 | 98.15 | -8.00 | 中信建投证券股份有限公 | 国泰海通证券股份有限公 | | | | | | 司北 ...

Group 1 - The metal new materials sector increased by 1.61% on January 22, with Tianli Composite leading the gains [1] - The Shanghai Composite Index closed at 4122.58, up 0.14%, while the Shenzhen Component Index closed at 14327.05, up 0.5% [1] - Key stocks in the metal new materials sector showed significant price increases, with Tianli Composite rising by 16.00% to a closing price of 107.50 [1] Group 2 - The sector experienced a net inflow of 265 million yuan from institutional investors, while retail investors saw a net outflow of 283 million yuan [2] - Major stocks like Tianli Composite and Sry New Materials had varying net inflows and outflows, indicating differing investor sentiment [3] - The trading volume and turnover for key stocks in the sector were substantial, with Tianli Composite achieving a turnover of 1.166 billion yuan [1][2]

转自：证券时报 人民财讯1月22日电，企查查APP显示，近日，山东墨龙新材料技术有限公司成立，法定代表人为宋广 杰，经营范围包含：新材料技术研发；新兴能源技术研发；风力发电技术服务；金属材料销售；集成电 路销售等。企查查股权穿透显示，该公司由山东墨龙、MPM INTERNATIONAL LIMITED共同持股。 ...

Group 1 - The core point of the news is that Srey New Materials Co., Ltd. experienced a stock price increase of 5.01%, reaching 44.00 CNY per share, with a trading volume of 479 million CNY and a turnover rate of 1.52%, resulting in a total market capitalization of 34.12 billion CNY [1] - Srey New Materials, established on July 11, 1995, is located in Xi'an, Shaanxi Province, and was listed on March 16, 2022. The company specializes in high-strength and high-conductivity copper alloy materials and products, medium and high-voltage electrical contact materials and products, high-performance metal chromium powder, CT and DR tube components, and next-generation copper-iron alloy materials [1] - The revenue composition of Srey New Materials includes: high-strength and high-conductivity copper alloy materials and products (46.51%), medium and high-voltage electrical contact materials and products (22.90%), other main businesses (14.09%), other supplementary (6.12%), medical imaging components (5.31%), and high-performance metal chromium powder (5.08%) [1] Group 2 - From the perspective of major fund holdings, data shows that one fund under Penghua Fund has a significant position in Srey New Materials. The Penghua Sci-Tech Innovation Board 200 ETF (588240) held 64,100 shares in the fourth quarter, accounting for 1.38% of the fund's net value, ranking as the sixth largest holding [2] - The Penghua Sci-Tech Innovation Board 200 ETF (588240) was established on February 13, 2025, with a latest scale of 180 million CNY. Year-to-date, it has achieved a return of 16.33%, ranking 218 out of 5542 in its category, and a cumulative return of 62.78% since inception [2]

Group 1 - The company is primarily engaged in the research, production, and sales of various PVD coating materials, metals, and alloy materials [5] - The company's performance fluctuation is attributed to a significant increase in R&D investment for special projects and terminal collaborations compared to the previous year [5] - To mitigate risks from raw material price volatility, the company has engaged in futures hedging and silver leasing business, which resulted in substantial investment losses and fair value changes during the reporting period [5] Group 2 - Historical net profit and non-recurring profit growth rates are presented, indicating fluctuations in profitability over the years [8] - The net profit and non-recurring profit have shown significant year-on-year changes, with projections indicating a continued decline in the coming years [9] - The company’s net profit and non-recurring profit have experienced quarterly variations, reflecting ongoing challenges in maintaining profitability [9]